Home/Filings/4/0001209191-19-061544
4//SEC Filing

Daly Timothy 4

Accession 0001209191-19-061544

CIK 0001636651other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:19 PM ET

Size

5.5 KB

Accession

0001209191-19-061544

Insider Transaction Report

Form 4
Period: 2019-12-18
Daly Timothy
VP, Finance & Corp. Controller
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-18+125,000125,000 total
    Exercise: $4.42Exp: 2029-12-17Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001535896

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:19 PM ET
Size
5.5 KB